Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
What one MAC covers, another may not
Indicated Cases This formulation is most appropriate for: Kittens and small adult cats under 2.5 kg with FIP and confirmed or suspected anaemia Neurological FIP presentations in the small cat weight range Cats presenting with significant appetite loss or weight decline at diagnosis Cases where the owner or attending veterinarian wishes to consolidate antiviral and nutritional support into a single daily injection Cats with a history of B12-responsive conditions alongside a new FIP diagnosis This Formulation Is Not the First Choice For Cats requiring therapeutic-dose B12 supplementation independently maintain a separate B12 protocol as directed Cats over 2.5 kg consider the 30mg/ml + B12 or 40mg/ml + B12 formulations Cases where the veterinarian has specifically indicated the non-B12 formulation Concentration Selection Guide Administration Administer subcutaneously once daily
BPC-157 500mcg + KPV 500mcg per unit Third-party tested batch documentation included USA tested and fulfilled For laboratory research use only BPC-157 and KPV Capsule (500mcg/500mcg) Research Overview BPC-157 and KPV (500mcg/500mcg) is a research-grade dual-peptide formulation combining BPC-157, a synthetic pentadecapeptide originally isolated from gastric juice protein, with KPV, a tripeptide derived from the C-terminal sequence of alpha-MSH
Subcutaneous injection Subcutaneous administration involves injecting into the fatty tissue just beneath the skin
Below is a clinicians view of why it happens, what counts as normal, and the warning signs that mean you should stop waiting it out and speak to a doctor
O.RubinB
